Skip to main content
Log in

Immunological studies of patients with tumours of the prostate and bladder

A retrospective analysis

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

A total of 25 patients with bladder tumour and 35 with prostatic tumour were tested for humoral and cellular immune responsiveness in 1977. Information on the subsequent course of disease was collected 5 years later and confronted with the results of these tests. The most marked deviations in the values of acute-phase proteins, complement and lymphocyte transformation tests were found in those patients who had died within the first year of the investigations. The results approached or attained the normal values parallel with the survival times.

The parameters studied thus seem to lend themselves to diagnostic and monitoring purposes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ablin, R. J.: Serum proteins in prostatic cancer.Urology, 7, 39 (1976).

    PubMed  Google Scholar 

  2. Ablin, R. J., Guinan, P. D., Sundar, B., Bush, J. M.: Immunostaging of patients with prostatic cancer: correlation of “immunostage” and clinical stage.Curr. Ther. Res., 20, 674 (1976).

    PubMed  Google Scholar 

  3. Bastable, J. R. G., Richards, B., Haworth, S., Cooper, H. S.: Acute phase reactant protein in the clinical management of carcinoma of the bladder.Br. J. Urol., 51, 283 (1979).

    PubMed  Google Scholar 

  4. Broders, A. C.: Carcinoma: grading and practical application.Arch. Pathol., 2, 376 (1926).

    Google Scholar 

  5. Byar, D. P.: The Veterans Administration Cooperative Urological Research Group's Studies: Cancer of the prostate.Cancer, 32, 1126 (1973).

    PubMed  Google Scholar 

  6. Catalona, W. J., Potvin, C., Chretien, P. B., Castle, J. R.: T lymphocytes in bladder and prostatic cancer patients.J. Urol., 112, 378 (1974).

    PubMed  Google Scholar 

  7. Cochran, A. J.: Man, Cancer and Immunity. Academic Press, London-New York-San Francisco 1978.

    Google Scholar 

  8. Cooper, E. H., Milford Ward, A.: Acute phase reactant proteins.Invest. Cell. Pathol., 2, 293 (1979).

    PubMed  Google Scholar 

  9. Deture, F. A., Deardourff, S. L., Kaufman, H. E., Centifano, Y. M.: A comparison of serum immunoglobulins from patients with non-neoplastic prostates and prostatic carcinoma.J. Urol., 120, 435 (1978).

    PubMed  Google Scholar 

  10. Dunzendorfer, U., Jung, K., Ohlenschläger, G.: Transferrin C3 complement, haptoglobin, plasminogen and alfa2-macroglobulin in patients with urogenital tumors.Eur. Urol., 6, 232 (1980).

    PubMed  Google Scholar 

  11. Halpern, B., Ky, N. T., Lagrue, G., Amache, N.: Le test aux lymphocytes en allergologie.Med. Hyg., 25, 55 (1967).

    Google Scholar 

  12. Jewett, H. J., Strong, G. H.: Infiltrating carcinoma of the bladder: relation of depth of penetration of the bladder wall to incidence of local extension and metastases.J. Urol., 55, 366 (1946).

    Google Scholar 

  13. Laurence, D. J. R., Neville, A. M.: Foetal antigens and their role in the diagnosis and clinical management of human neoplasms. A review.Br. J. Cancer, 26, 335 (1972).

    PubMed  Google Scholar 

  14. Mancini, G., Carbonara, A. O., Heremans, J. F.: Immunochemical quantitation of antigens by single radial immunodiffusions.Immunochemistry, 2, 235 (1968).

    Google Scholar 

  15. Milford Ward, A., Cooper, E. H., Turner, R., Anderson, J. A., Neville, I. M.: Acutephase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes.Br. J. Cancer, 35, 170 (1977).

    PubMed  Google Scholar 

  16. Mostofi, F. K.: Histological typing of prostate tumours. WHO, Geneva 1980.

    Google Scholar 

  17. Robinson, M. R. G., Nakhla, L. S., Whitaker, R. H.: A new concept in the management of carcinoma of the prostate.Br. J. Urol., 43, 728 (1971).

    PubMed  Google Scholar 

  18. Romics, I., Fehér, J., Horváth, J., Kisbenedek, L., Balogh, F.: Immunoreactivity in patients with bladder cancer.Orv. Hetil., 122, 1847 (1981).

    PubMed  Google Scholar 

  19. Romics, I., Fehér, J., Horváth, J., Kisbenedek, L., Balogh, F.: Klinische und immunologische Untersuchungen bei Patienten mit Prostatatumoren.Z. Urol. Nephrol., 74, 567 (1981).

    PubMed  Google Scholar 

  20. Romics, I., Horváth, J., Kisbenedek, L., Balogh, F.: Examinations of the immunoreactivity in patients with urogenital tumours.Urol. Nephrol. Szle, 7, 58 (1980).

    Google Scholar 

  21. Romics, I., Horváth, J.: Non specific lymphocyte transformation in urologic cancer patients.Int. Urol. Nephrol., 10, 261 (1978).

    PubMed  Google Scholar 

  22. Schmidt, J. D., Feldbesch, T. L., Weinstein, S. H., Bonney, W. W.: Serum immunoglobulins in genitourinary malignancies.J. Urol., 115, 293 (1976).

    PubMed  Google Scholar 

  23. Trautner, K., Cooper, E. H., Haworth, S., Milford Ward, S. M.: An evaluation of serum protein profiles in the long-term surveillance of prostatic cancer.Scand. J. Urol. Nephrol., 14, 143 (1980).

    PubMed  Google Scholar 

  24. Wells, J. V.: Immunology of genitourinary tumors. In: Smith, D. R. (ed.): General Urology. Lange Med. Publ., California 1977.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romics, I., Fehér, J. & Horváth, J. Immunological studies of patients with tumours of the prostate and bladder. International Urology and Nephrology 15, 339–345 (1983). https://doi.org/10.1007/BF02082554

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02082554

Keywords

Navigation